ACS Pharmacology and Translational Science

SJR Rank #5,407H-index: 51SJR: 0.942Best quartile: Q2APC: US$4,500
Journal website: aims, scope and author guidelines
Publisher

American Chemical Society

Country

United States

Type

journal

SJR by Edition

2022202500.40.81.21.6

Subject Categories

  • PharmacologyQ2
  • Pharmacology (medical)Q2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Receptor Mechanisms and SignalingAcademic Writing and PublishingComputational Drug Discovery MethodsNeuropeptides and Animal PhysiologySARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchPsychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchRNA Interference and Gene Delivery

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025080160240320

Detailed Information

ISSN

2575-9108

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

4.18

References per Document

73.00

Coverage

2018-2026

Scope

ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered.

Metrics from SCImago Journal Rank 2025. View on SCImago